Evommune (EVMN) Current Leases (2024 - 2026)

Evommune (EVMN) has 3 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• Current Leases for Q1 2026 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY), and the FY2025 annual result was $242000.0, down 50.31% from the prior year.
• Current Leases advanced to $1.3 million in Q1 2026 per EVMN's latest filing, from $242000.0 in the prior quarter.
• Over five years, Current Leases peaked at $1.3 million in Q1 2026 and troughed at $160000.0 in Q3 2025.
• A 3-year average of $535500.0 and a median of $364500.0 in 2024 frame the typical range for Current Leases.
• On a YoY basis, Current Leases climbed as much as 50.31% in 2025 and fell as far as 50.31% in 2025.
• A 3-year view of Current Leases shows it stood at $487000.0 in 2024, then slumped by 50.31% to $242000.0 in 2025, then soared by 417.77% to $1.3 million in 2026.
• Business Quant data shows EVMN's Current Leases at $1.3 million in Q1 2026, $242000.0 in Q4 2025, and $160000.0 in Q3 2025.